ESC Premium Access

Economic outcomes of the CAT-CAD randomised trial assessing coronary artery computed tomography as the first-choice anatomic test for individuals with suspected significant coronary artery disease


About the speaker

Doctor Piotr Nikodem Rudzinski

National Institute of Cardiology, Warsaw (Poland)
0 follower

6 more presentations in this session

Diagnostic accuracy of hyperemic instantaneous wave-free ratio for obstructive coronary artery disease based on lesion location

Speaker: Doctor H. Takahashi (Tokyo, JP)


Prediction of standard of care guided coronary revascularisation by FFRct is preserved across a broad range of coronary calcification.

Speaker: Doctor D. Akkan (Slagelse, DK)


The new biomarkers in coronary artery disease - the diagnostic and prognostic value of insulin like growth factor binding protein 7 (IGFBP 7) and galectin 3 (Gal 3).

Speaker: Doctor A. Lisowska (Bialystok, PL)


COMBINE OCT and FFR assessment of non culprit lesions to better predict adverse event outcomes in diabetes mellitus patients. Rationale, design and initial OCT results

Speaker: Doctor E. Kedhi (Brugge, BE)


FFRct to predict coronary revascularisation - a real-world experience

Speaker: Doctor D. Akkan (Slagelse, DK)


Access the full session

Diagnostic modalities in stable CAD

Speakers: Doctor P. Rudzinski, Doctor H. Takahashi, Doctor D. Akkan, Doctor A. Lisowska, Doctor E. Kedhi...

About the event



26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk